<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medlit</journal-id><journal-title-group><journal-title xml:lang="ru">Гигиена и санитария</journal-title><trans-title-group xml:lang="en"><trans-title>Hygiene and Sanitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0016-9900</issn><issn pub-type="epub">2412-0650</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47470/0016-9900-2024-103-10-1230-1234</article-id><article-id custom-type="edn" pub-id-type="custom">pgvpsa</article-id><article-id custom-type="elpub" pub-id-type="custom">medlit-4425</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОФИЛАКТИЧЕСКАЯ ТОКСИКОЛОГИЯ И ГИГИЕНИЧЕСКОЕ НОРМИРОВАНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PREVENTIVE TOXICOLOGY AND HYGIENIC STANDARTIZATION</subject></subj-group></article-categories><title-group><article-title>Полиморфизм гена D2-рецептора дофамина ANKK1/DRD2 (rs18004976) и особенности нейроиммунного профиля детей Северо-Восточной и Юго-Восточной Сибири в условиях аэрогенной экспозиции бенз(а)пиреном</article-title><trans-title-group xml:lang="en"><trans-title>Dopamine D2 receptor ANKK1/DRD2 gene (rs18004976) polymorphism and features of the neuroimmune profile in children in North-Eastern and South-Eastern Siberia under exposure to airborne benzo(a)pyrene</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4860-3145</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Долгих</surname><given-names>Олег Владимирович</given-names></name><name name-style="western" xml:lang="en"><surname>Dolgikh</surname><given-names>Oleg V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор мед. наук, зав. отд. иммунобиологических методов диагностики ФБУН «ФНЦ МПТ УРЗН», 614045, Пермь, Россия</p><p>e-mail: oleg@fcrisk.ru</p></bio><bio xml:lang="en"><p>DSc (Medicine), head of the Department of Immunobiological Diagnostic Methods of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation</p><p>e-mail: oleg@fcrisk.ru</p></bio><email xlink:type="simple">oleg@fcrisk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2356-1145</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зайцева</surname><given-names>Нина Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Zaitseva</surname><given-names>Nina V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор мед. наук, профессор, академик РАН, научный руководитель ФБУН «ФНЦ МПТ УРЗН», 614045, Пермь, Россия</p><p>e-mail: znv@fcrisk.ru</p></bio><bio xml:lang="en"><p>DSc (Medicine), Professor, Academician of the Russian Academy of Sciences Scientific Director of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation</p><p>e-mail: znv@fcrisk.ru</p></bio><email xlink:type="simple">znv@fcrisk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7271-9477</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никоношина</surname><given-names>Наталья Алексеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Nikonoshina</surname><given-names>Natalya A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мл. науч. сотр. лаб. иммунологии и аллергологии, аспирант ФБУН «ФНЦ МПТ УРЗН», 614045, Пермь, Россия</p><p>e-mail: nat08.11@yandex.ru</p></bio><bio xml:lang="en"><p>Junior researcher at the Laboratory of Immunology and Allergology, post-graduate student at the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation</p><p>e-mail: nat08.11@yandex.ru</p></bio><email xlink:type="simple">nat08.11@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФБУН «Федеральный научный центр медико-профилактических технологий управления рисками здоровью населения» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Scientific Center for Medical and Preventive Health Risk Management Technologies</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>19</day><month>11</month><year>2024</year></pub-date><volume>103</volume><issue>10</issue><fpage>1230</fpage><lpage>1234</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Долгих О.В., Зайцева Н.В., Никоношина Н.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Долгих О.В., Зайцева Н.В., Никоношина Н.А.</copyright-holder><copyright-holder xml:lang="en">Dolgikh O.V., Zaitseva N.V., Nikonoshina N.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rjhas.ru/jour/article/view/4425">https://www.rjhas.ru/jour/article/view/4425</self-uri><abstract><sec><title>Введение</title><p>Введение. Анализ специфики нейроиммунного профиля и полиморфизма кандидатных генов — важное направление выявления маркёров воздействия химических факторов на население северных территорий.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Обследованы дети Северо-Восточной и Юго-Восточной Сибири (n = 1253). Установлены концентрации бенз(а)пирена в крови методом высокоэффективной жидкостной хроматографии. Полиморфизм гена ANKK1/DRD2 исследовали методом полимеразной цепной реакции. Концентрацию IgG, специфического к бенз(а)пирену, определяли аллергосорбентными тестами, концентрацию дофамина — методом ИФА.</p></sec><sec><title>Результаты</title><p>Результаты. У детей в условиях экспозиции бенз(а)пиреном в дозе 0,0073 мкг/(кг ∙ день) на приполярной территории (Северо-Восточная Сибирь) выявлен повышенный риск ассоциированного с Т-аллелем и TT-генотипом гена ANKK1/DRD2 гаптенной гиперсенсибилизации, угнетения дофаминэргической регуляции, а также контаминации биосред бенз(а)пиреном, который сопоставим с подобными изменениями нейроиммунной регуляции у детей в процессе экспозиции данным полициклическим ароматическим углеводородом в дозе 0,0858 мкг/(кг ∙ день) в Юго-Восточной Сибири, связанными с С-аллелем и СС-генотипом этого гена.</p><p>Ограничения исследования связаны с ограниченным размером выборки, что требует верификации результатов в дальнейших наблюдениях.</p></sec><sec><title>Заключение</title><p>Заключение. У детей при низкодозовом воздейстии бенз(а)пирена на севере Восточной Сибири повышается вероятность ассоциированных с Т-аллелем и TT-генотипом гена ANKK1/DRD2 нарушений нейроиммунного статуса, аналогичных со связанными с С-аллелем и СС-генотипом гена ANKK1/DRD2 (rs1800497) (OR = 1,69–1,72; p &lt; 0,05) изменениями нейроиммунного профиля при высокодозовой экспозиции бенз(а)пиреном (0,0858 мкг/(кг ∙ день) в Юго-Восточной Сибири. Это подтверждает повышение чувствительности организма к влиянию химических факторов в климатических условиях севера.</p><p>Эти изменения нейроиммунного профиля у детей, проживающих в Северо-Восточной Сибири, связаны с Т-аллелем и ТТ-генотипом гена ANKK1/DRD2 (rs1800497) (OR=2,17–2,83, p &lt; 0,05), а также С-аллелем и СС-генотипом этого гена у детей, проживающих в Южной Сибири. Восточная Сибирь (OR=1,69–1,72, p &lt; 0,05).</p><p>Соблюдение этических стандартов. Исследование проведено с соблюдением основ Хельсинкской декларации ВМА и одобрено ЛЭК ФБУН «ФНЦ медико-профилактических технологий управления рисками здоровью населения» (протокол заседания № 2 от 17.01.2022 г.). До начала исследования было получено письменное информированное согласие законных представителей детей.</p></sec><sec><title>Участие авторов</title><p>Участие авторов: Долгих О.В. — концепция и дизайн исследования, редактирование; Зайцева Н.В. — редактирование; Никоношина Н.А. — сбор материала и обработка данных, написание текста. Все соавторы — утверждение окончательного варианта статьи, ответственность за целостность всех частей статьи.</p></sec><sec><title>Конфликт интересов</title><p>Конфликт интересов. Авторы декларируют отсутствие явных и потенциальных конфликтов интересов в связи с публикацией данной статьи.</p></sec><sec><title>Финансирование</title><p>Финансирование. Исследование не имело финансовой поддержки.</p></sec><sec><title>Поступила</title><p>Поступила: 12.08.2024 / Принята к печати: 02.10.2024 / Опубликована: 19.11.2024</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Examining peculiarities of neuroimmune profiles and candidate gene polymorphism is a relevant trend in identifying markers of effects and sensitivity to chemical exposures in northern areas. </p></sec><sec><title>Materials and methods</title><p>Materials and methods. We examined one thousand two hundred fifty three children residing in North-Eastern and South-Eastern Siberia. Blood benzo(a)pyrene levels were detected by HPLC. The ANKK1/DRD2 (rs18004976) gene polymorphism was studied using real-time PCR. IgG to benzo(a)pyrene levels were identified by allergosorbent testing. Dopamine levels were identified by using ELISA.</p></sec><sec><title>Results</title><p>Results. Exposure to airborne benz(a)pyrene in an industrial center in North-Eastern Siberia at the dose of 0.0073 µg/(kg ∙ day) causes an elevated risk of specific hapten hypersensitivity (IgG to benzo(a)pyrene), inhibition of dopaminergic regulation (dopamine deficiency), and elevated benzo(a)pyrene contamination in biological media. The identified changes are similar to those established in children exposed to this polycyclic aromatic hydrocarbon at the dose of 0.0858 µg/(kg ∙ day) in South-Eastern Siberia.</p></sec><sec><title>Limitations</title><p>Limitations. The sample needs expanding and any results obtained by further observations should be verified.</p></sec><sec><title>Conclusion</title><p>Conclusion. Children exposed to low doses of benzo(a)pyrene (0.0073 µg/(kg ∙ day)) in North-Eastern Siberia have elevated risks of disorders in the neuroimmune profile associated with the T-allele and TT genotype (rs1800497) of the ANKK1/DRD2 gene (OR =2.17 – 2.83, p&lt;0.05) (hyperproduction of IgG to benzo(a)pyrene, dopamine deficiency), which are comparable with similar changes in the neuroimmune profile associated with C-allele and CC-genotype of the ANKK1/DRD2 gene (rs1800497) (OR=1.69 – 1.72, p&lt;0.05) under exposure to benzo(a)pyrene at the dose of 0.0858 µg /(kg ∙ day) in South-Eastern Siberia. This indicates to the higher sensitivity of the body to chemical exposures in specific climatic conditions in northern areas.</p><p>Compliance with ethical standards. The study was conducted in compliance with the principles of the WMA Helsinki Declaration and approved by the LEC of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies (the meeting report No. 2 dated January 17, 2022). The study participants provided their informed consent.</p></sec><sec><title>Contribution</title><p>Contribution: Dolgikh O.V. — the study concept and design, editing; Zaitseva N.V. — editing; Nikonoshina N.A. — data collection and analysis, writing the text. All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.</p></sec><sec><title>Conflict of interest</title><p>Conflict of interest. The authors declare no conflict of interest.</p></sec><sec><title>Acknowledgement</title><p>Acknowledgement. The study had no sponsorship.</p></sec><sec><title>Received</title><p>Received: August 12, 2024 / Accepted: October 2, 2024 / Published: November 19, 2024</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>бенз(а)пирен</kwd><kwd>дофамин</kwd><kwd>генетический полиморфизм</kwd><kwd>нейроиммунный профиль</kwd><kwd>приполярная территория</kwd></kwd-group><kwd-group xml:lang="en"><kwd>benzo(a)pyrene</kwd><kwd>children</kwd><kwd>dopamine</kwd><kwd>neuroimmune profile</kwd><kwd>genetic polymorphism</kwd><kwd>circumpolar territory</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Chang Y., Siddens L.K., Heine L.K., Sampson D.A., Yu Z., Fischer K.A., et al. Comparative mechanisms of PAH toxicity by benzo[a]pyrene and dibenzo[def,p]chrysene in primary human bronchial epithelial cells cultured at air-liquid interface. Toxicol. Appl. Pharmacol. 2019; 379: 114644. https://doi.org/10.1016/j.taap.2019.114644</mixed-citation><mixed-citation xml:lang="en">Chang Y., Siddens L.K., Heine L.K., Sampson D.A., Yu Z., Fischer K.A., et al. Comparative mechanisms of PAH toxicity by benzo[a]pyrene and dibenzo[def,p]chrysene in primary human bronchial epithelial cells cultured at air-liquid interface. Toxicol. Appl. Pharmacol. 2019; 379: 114644. https://doi.org/10.1016/j.taap.2019.114644</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Deng Y.L., Liao J.Q., Zhou B., Zhang W.X., Liu C., Yuan X.Q., et al. Early life exposure to air pollution and cell-mediated immune responses in preschoolers. Chemosphere. 2022; 286(Pt. 3): 131963. https://doi.org/10.1016/j.chemosphere.2021.131963</mixed-citation><mixed-citation xml:lang="en">Deng Y.L., Liao J.Q., Zhou B., Zhang W.X., Liu C., Yuan X.Q., et al. Early life exposure to air pollution and cell-mediated immune responses in preschoolers. Chemosphere. 2022; 286(Pt. 3): 131963. https://doi.org/10.1016/j.chemosphere.2021.131963</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Das L., Patel B., Patri M. Adolescence benzo[a]pyrene treatment induces learning and memory impairment and anxiolytic like behavioral response altering neuronal morphology of hippocampus in adult male Wistar rats. Toxicol. Rep. 2019; 6: 1104–13. https://doi.org/10.1016/j.toxrep.2019.10.014</mixed-citation><mixed-citation xml:lang="en">Das L., Patel B., Patri M. Adolescence benzo[a]pyrene treatment induces learning and memory impairment and anxiolytic like behavioral response altering neuronal morphology of hippocampus in adult male Wistar rats. Toxicol. Rep. 2019; 6: 1104–13. https://doi.org/10.1016/j.toxrep.2019.10.014</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Liu D., Zhao Y., Qi Y., Gao Y., Tu D., Wang Y., et al. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice. J. Neuroinflammation. 2020; 17(1): 258. https://doi.org/10.1186/s12974-020-01925-y</mixed-citation><mixed-citation xml:lang="en">Liu D., Zhao Y., Qi Y., Gao Y., Tu D., Wang Y., et al. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice. J. Neuroinflammation. 2020; 17(1): 258. https://doi.org/10.1186/s12974-020-01925-y</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cherif L.S., Cao-Lei L., Farinelle S., Muller C.P., Turner J.D., Schroeder H., et al. Assessment of 9-OH- and 7,8-diol-benzo[a]pyrene in blood as potent markers of cognitive impairment Related to benzo[a]pyrene exposure: an animal model study. Toxics. 2021; 9(3): 50. https://doi.org/10.3390/toxics9030050</mixed-citation><mixed-citation xml:lang="en">Cherif L.S., Cao-Lei L., Farinelle S., Muller C.P., Turner J.D., Schroeder H., et al. Assessment of 9-OH- and 7,8-diol-benzo[a]pyrene in blood as potent markers of cognitive impairment Related to benzo[a]pyrene exposure: an animal model study. Toxics. 2021; 9(3): 50. https://doi.org/10.3390/toxics9030050</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang W., Tian F., Zheng J., Li S., Qiang M. Chronic administration of benzo(a)pyrene induces memory impairment and anxiety-like behavior and increases of NR2B DNA methylation. PLoS One. 2016; 11(2): e0149574. https://doi.org/10.1371/journal.pone.0149574</mixed-citation><mixed-citation xml:lang="en">Zhang W., Tian F., Zheng J., Li S., Qiang M. Chronic administration of benzo(a)pyrene induces memory impairment and anxiety-like behavior and increases of NR2B DNA methylation. PLoS One. 2016; 11(2): e0149574. https://doi.org/10.1371/journal.pone.0149574</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dai W.L., Bao Y.N., Fan J.F., Ma B., Li S.S., Zhao W.L., et al. Blockade of spinal dopamine D1/D2 receptor suppresses activation of NMDA receptor through Gαq and Src kinase to attenuate chronic bone cancer pain. J. Adv. Res. 2020; 28: 139–48. https://doi.org/10.1016/j.jare.2020.08.005</mixed-citation><mixed-citation xml:lang="en">Dai W.L., Bao Y.N., Fan J.F., Ma B., Li S.S., Zhao W.L., et al. Blockade of spinal dopamine D1/D2 receptor suppresses activation of NMDA receptor through Gαq and Src kinase to attenuate chronic bone cancer pain. J. Adv. Res. 2020; 28: 139–48. https://doi.org/10.1016/j.jare.2020.08.005</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Suzuki T., Hidaka T., Kumagai Y., Yamamoto M. Environmental pollutants and the immune response. Nat. Immunol. 2020; 21(12): 1486–95. https://doi.org/10.1038/s41590-020-0802-6</mixed-citation><mixed-citation xml:lang="en">Suzuki T., Hidaka T., Kumagai Y., Yamamoto M. Environmental pollutants and the immune response. Nat. Immunol. 2020; 21(12): 1486–95. https://doi.org/10.1038/s41590-020-0802-6</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cui W., Aida T., Ito H., Kobayashi K., Wada Y., Kato S., et al. dopaminergic signaling in the nucleus accumbens modulates stress-coping strategies during inescapable stress. J. Neurosci. 2020; 40(38): 7241–54. https://doi.org/10.1523/JNEUROSCI.0444-20.2020</mixed-citation><mixed-citation xml:lang="en">Cui W., Aida T., Ito H., Kobayashi K., Wada Y., Kato S., et al. dopaminergic signaling in the nucleus accumbens modulates stress-coping strategies during inescapable stress. J. Neurosci. 2020; 40(38): 7241–54. https://doi.org/10.1523/JNEUROSCI.0444-20.2020</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Зайцева Н.В., Долгих О.В., Никоношина Н.А., Алексеев В.Б. Полиморфизм генов-кандидатов формирования «синдрома полярного напряжения» у детей. Якутский медицинский журнал. 2024; (1): 70–4. https://doi.org/10.25789/YMJ.2024.85.18 https://elibrary.ru/tnlhgi</mixed-citation><mixed-citation xml:lang="en">Zaitseva N.V., Dolgikh O.V., Nikonoshina N.A., Alekseev V.B. Polymorphism of candidate genes for the formation of “polar stress syndrome” in children. Yakutskii meditsinskii zhurnal. 2024; (1): 70–4. https://doi.org/10.25789/YMJ.2024.85.18 https://elibrary.ru/tnlhgi (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Шур П.З., Хасанова А.А., Цинкер М.Ю., Зайцева Н.В. Методические подходы к оценке риска здоровью населения в условиях сочетанного воздействия климатических факторов и обусловленного ими химического загрязнения атмосферы. Анализ риска здоровью. 2023; (2): 58–69. https://doi.org/10.21668/health.risk/2023.2.05 https://elibrary.ru/ebqchy</mixed-citation><mixed-citation xml:lang="en">Shur P.Z., Khasanova A.A., Tsinker M.Yu., Zaitseva N.V. Methodical approaches to assessing public health risks under combined exposure to climatic factors and chemical air pollution caused by them. Health Risk Analysis. 2023; (2): 58–69. https://doi.org/10.21668/health.risk/2023.2.05 https://elibrary.ru/ebqchy (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Решение Дудинского городского совета депутатов № 10-0358 «Об утверждении Программы комплексного развития транспортной инфраструктуры муниципального образования «Город Дудинка»»; 2017. Доступно: https://pravo-dudinka.ru/download/rgs/rgs_2017-09-14_10-0358.pdf</mixed-citation><mixed-citation xml:lang="en">Decision of the Dudinsky City Council No. 10-0358 «In the approval of the program for the integrated development of the transport infrastructure in the municipal formation “Dudinka”»; 2017. Available at: https://pravo-dudinka.ru/download/rgs/rgs_2017-09-14_10-0358.pdf (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Государственный доклад «О состоянии и об охране окружающей среды Российской Федерации в 2018 году». М.; 2019.</mixed-citation><mixed-citation xml:lang="en">State Report «On the state and environmental protection of the Russian Federation in 2018». Moscow; 2019. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Состояние загрязнения атмосферы в городах на территории России за 2017 г.: Ежегодник. СПб.; 2018.</mixed-citation><mixed-citation xml:lang="en">The State of Atmospheric Pollution in Cities in Russia for 2017: Yearbook [Sostoyanie zagryazneniya atmosfery v gorodakh na territorii Rossii za 2017 g.: Ezhegodnik]. St. Petersburg; 2018. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Клиническое руководство Тица по лабораторным тестам под ред. Алана Ву А.Х.Б. Пер. с англ. М.: Лабора; 2013.</mixed-citation><mixed-citation xml:lang="en">Wu A.H.B., ed. Tietz Clinical Guide to Laboratory Tests. Elsevier; 2006.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Liu L., Wu Y., Wang B., Jiang Y., Lin L., Li X., et al. DA-DRD5 signaling controls colitis by regulating colonic M1/M2 macrophage polarization. Cell Death Dis. 2021; 12(6): 500. https://doi.org/10.1038/s41419-021-03778-6</mixed-citation><mixed-citation xml:lang="en">Liu L., Wu Y., Wang B., Jiang Y., Lin L., Li X., et al. DA-DRD5 signaling controls colitis by regulating colonic M1/M2 macrophage polarization. Cell Death Dis. 2021; 12(6): 500. https://doi.org/10.1038/s41419-021-03778-6</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Mikulak J., Bozzo L., Roberto A., Pontarini E., Tentorio P., Hudspeth K., et al. Dopamine inhibits the effector functions of activated NK cells via the upregulation of the D5 receptor. J. Immunol. 2014; 193(6): 2792–800. https://doi.org/10.4049/jimmunol.1401114</mixed-citation><mixed-citation xml:lang="en">Mikulak J., Bozzo L., Roberto A., Pontarini E., Tentorio P., Hudspeth K., et al. Dopamine inhibits the effector functions of activated NK cells via the upregulation of the D5 receptor. J. Immunol. 2014; 193(6): 2792–800. https://doi.org/10.4049/jimmunol.1401114</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Li M., Zhou L., Sun X., Yang Y., Zhang C., Wang T., et al. Dopamine, a co-regulatory component, bridges the central nervous system and the immune system. Biomed. Pharmacother. 2022; 145: 112458. https://doi.org/10.1016/j.biopha.2021.112458</mixed-citation><mixed-citation xml:lang="en">Li M., Zhou L., Sun X., Yang Y., Zhang C., Wang T., et al. Dopamine, a co-regulatory component, bridges the central nervous system and the immune system. Biomed. Pharmacother. 2022; 145: 112458. https://doi.org/10.1016/j.biopha.2021.112458</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Qi Y.Z., Quan H.H., Xu W.X., Li Q.R., Zhou H. 苯并[a]芘对脑内多巴胺能神经元和α-突触核蛋白的影响及其机制. Beijing Da Xue Xue Bao Yi Xue Ban. 2020; 52(3): 438–43. https://doi.org/10.19723/j.issn.1671-167X.2020.03.007 (in Chinese)</mixed-citation><mixed-citation xml:lang="en">Qi Y.Z., Quan H.H., Xu W.X., Li Q.R., Zhou H. Effect of benzo(a)pyrene on dopaminergic neurons and α-synuclein in brain and its mechanism involved. Beijing Da Xue Xue Bao Yi Xue Ban. 2020; 52(3): 438–43. https://doi.org/10.19723/j.issn.1671-167X.2020.03.007 (in Chinese)</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Rył A., Tomska N., Jakubowska A., Ogrodniczak A., Palma J., Rotter I. Genetic aspects of problematic and risky internet use in young men-analysis of ANKK1, DRD2 and NTRK3 gene polymorphism. Genes (Basel). 2024; 15(2): 169. https://doi.org/10.3390/genes15020169</mixed-citation><mixed-citation xml:lang="en">Rył A., Tomska N., Jakubowska A., Ogrodniczak A., Palma J., Rotter I. Genetic aspects of problematic and risky internet use in young men-analysis of ANKK1, DRD2 and NTRK3 gene polymorphism. Genes (Basel). 2024; 15(2): 169. https://doi.org/10.3390/genes15020169</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao F., Cheng Z., Piao J., Cui R., Li B. Dopamine receptors: is it possible to become a therapeutic target for depression? Front. Pharmacol. 2022; 13: 947785. https://doi.org/10.3389/fphar.2022.947785</mixed-citation><mixed-citation xml:lang="en">Zhao F., Cheng Z., Piao J., Cui R., Li B. Dopamine receptors: is it possible to become a therapeutic target for depression? Front. Pharmacol. 2022; 13: 947785. https://doi.org/10.3389/fphar.2022.947785</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
